Flow resistance modulated aerosolized active agent delivery
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 2, 2013
Grant Date -
Nov 14, 2002
app pub date -
Oct 7, 1999
filing date -
Oct 9, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at a low inspiratory flow rate for an initial period of time to increase bioavailability of the active agent.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully